13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001047859
Total reported value
$73.6M
$73.6M
13 檔
46.8%
The Q1 2025 SEC filing reveals that Paragon Associates & Paragon Associates Ii Joint Venture held a total portfolio value of $73.6M, covering 13 public equity positions.
In Q1 2025, Paragon Associates & Paragon Associates Ii Joint Venture displayed an active expansion posture, initiating 13 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 33.03% | -10.58% | +4.00% | |
| 2 | NVGS | Navigator Holdings Ltd. | Stock-Other | 18.72% | -2.87% | — | |
| 3 | EPSN | Epsilon Energy LTD | Stock-Other | 12.33% | -0.79% | — | |
| 4 | BELFB | Bel Fuse Inc-cl B | Stock-Other | 10.88% | -0.53% | EXIT | |
| 5 | NPKI | Npk International Inc | Stock-Other | 5.79% | -2.47% | +466.67% | |
| 6 | FNV | Franco-nevada CORP | Stock-Materials | 5.54% | — | -57.14% | |
| 7 | DMAC | Diamedica Therapeutics Inc | Stock-Other | 5.33% | -6.34% | +16.55% | |
| 8 | IRIX | Iridex CORP | Stock-Other | 2.32% | -0.99% | — | |
| 9 | ✓ | Akoya Biosciences Inc | Stock-Other | 2.19% | — | -16.23% | |
| 10 | CDNA | Caredx Inc | Stock-Other | 2.08% | -2.80% | — | |
| 11 | KSPI | Jsc Kaspi.kz Adr | Stock-Other | 1.09% | — | — | |
| 12 | QTRX | Quanterix CORP | Stock-Other | 0.38% | -0.33% | EXIT | |
| 13 | PRGO | Perrigo Company plc | Stock-Healthcare | 0.33% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AEM | Agnico Eagle Mines LTD | — | NEW | New buy |
| 2 | NVGS | Navigator Holdings Ltd. | — | NEW | New buy |
| 3 | EPSN | Epsilon Energy LTD | — | NEW | New buy |
| 4 | BELFB | Bel Fuse Inc-cl B | — | NEW | New buy |
| 5 | NPKI | Npk International Inc | — | NEW | New buy |
| 6 | FNV | Franco-nevada CORP | — | NEW | New buy |
| 7 | DMAC | Diamedica Therapeutics Inc | — | NEW | New buy |
| 8 | IRIX | Iridex CORP | — | NEW | New buy |
| 9 | ✓ | Akoya Biosciences Inc | — | NEW | New buy |
| 10 | CDNA | Caredx Inc | — | NEW | New buy |
| 11 | KSPI | Jsc Kaspi.kz Adr | — | NEW | New buy |
| 12 | QTRX | Quanterix CORP | — | NEW | New buy |
| 13 | PRGO | Perrigo Company plc | — | NEW | New buy |
According to official SEC Form 13F filings, Paragon Associates & Paragon Associates Ii Joint Venture reported a total U.S. public equity portfolio value of $73.6M across 13 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including AEM, NVGS, EPSN) accounted for 46.8% of total reported equity market value during Q1 2025.
Top New Position Initiated
AEM
市值: $14.1M
During Q1 2025, Paragon Associates & Paragon Associates Ii Joint Venture's top holdings by market value included AEM (33.0%)、NVGS (18.7%)、EPSN (12.3%). The largest single position, AEM, represented 33.0% of total portfolio value.
In Q1 2025, Paragon Associates & Paragon Associates Ii Joint Venture made 13 total portfolio adjustments, initiating 13 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.